PAX3 and rhabdomyosarcoma: It is not unprecedented that the number of binding sites for a particular factor is far greater than the number of genes that are differentially expressed when that factor is induced, as was the case with the myogenesis regulator MyoD [32], or the PAX3-FKHR fusion associated with rhabdomyosarcoma [33].